Ščudla V.1, Schneiderka P.2, Pika T.1, Minařík J.1, Bačovský J.1, Farbiaková V.3:
Clinical importance of evaluating serum
levels of free light chains of immunoglobulins in monoclonal gammopathies
|
76 |
Maisnar V.1, 3, Hájek R.2, 3:
Revision of criteria for the diagnosis and evaluation of response to therapy in multiple myeloma
|
84 |
Špička I.1, Mecl J.2, Benáková H.3, Nohejlová A.1, Straub J.1, Novotová E.1, Zima T.3:
Comparing the detection of monoclonal
protein by means of presently available biochemocal methods
|
89 |
Tichý M.1, Vávrová J.1, Friedecký B.1, Maisnar V.2:
Methods for detection of free immunoglobulin light chains
|
93 |
Vávrová J.1, Friedecký B.1, Tichý M.1, Holečková M.1, Maisnar V.2, Hájek R.3:
The determination of free light chains by
immunoturbidimetry and ELISA
|
97 |
Pika T.1, Minařík J.1, Zemanová M.1, Schneiderka P.2, Bačovský J.1, Šlézar J.3, Ščudla V.1:
Serum free light chain
immunoglobulin levels in multiple myeloma and monoclonal gammopathy of undetermined significance
|
102 |
Granátová J.1, Bolková M.1, Fantová L.2, Hornová L.2, Mašková Z.3, Horák J.4, Lánská V.5:
Free light chains of
immunoglobulins in patient with renal insufficiency
|
106 |
